Literature DB >> 20398860

Chagas disease and stroke.

Francisco Javier Carod-Artal1, Joaquim Gascon.   

Abstract

Chagas disease is a neglected infectious disease in the tropics and an emerging health problem in Europe and the USA. In the past decade, a link has been recorded between ischaemic stroke and Trypanosoma cruzi infection in several epidemiological studies, and an increase in stroke prevalence is expected with the ageing of the population infected with T cruzi in Latin America. Heart failure, mural thrombus, left ventricular apical aneurysm, and several types of cardiac arrhythmias are associated with stroke in Chagas disease. Stroke could also be the first sign of Chagas disease in asymptomatic patients and those with mild systolic dysfunction, so patients with stroke who are from endemic regions should be screened for T cruzi infection. The most frequent stroke syndrome seen in patients with Chagas disease is partial anterior circulation infarction. Stroke recurrence has been estimated to occur in 20% of patients, and secondary prevention measures include chronic anticoagulation in cardioembolic chagasic stroke. So far, no studies have been done to assess the effect of chagasic stroke on vascular dementia. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20398860     DOI: 10.1016/S1474-4422(10)70042-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  34 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

Review 2.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

3.  Epidemiology of concurrent Chagas disease and ischemic stroke in a population attending a multicenter quaternary rehabilitation network in Brazil.

Authors:  Vinícius Viana Abreu Montanaro; Thiago Falcão Hora; Creuza Maria da Silva; Carla Verônica de Viana Santos; Maria Inacia Ruas Lima; Eleonora Maria de Jesus Oliveira; Gabriel R de Freitas
Journal:  Neurol Sci       Date:  2019-07-30       Impact factor: 3.307

4.  Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment.

Authors:  José A Pérez-Molina; Francesca Norman; Rogelio López-Vélez
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

5.  In silico approach for the identification of immunological properties of enolase from Trypanosoma cruzi and its possible usefulness as vaccine in Chagas disease.

Authors:  Alejandro Carabarín-Lima; Olivia Rodríguez-Morales; María Cristina González-Vázquez; Lidia Baylón-Pacheco; Pedro A Reyes; Minerva Arce-Fonseca; José Luis Rosales-Encina
Journal:  Parasitol Res       Date:  2014-01-19       Impact factor: 2.289

6.  Viral and parasitic pathogen burden and the association with stroke in a population-based cohort.

Authors:  Brad D Pearce; Anna Bracher; Jeffrey L Jones; Deanna Kruszon-Moran
Journal:  Int J Stroke       Date:  2017-09-15       Impact factor: 5.266

7.  Chagas Heart Failure in Patients from Latin America.

Authors:  Reinaldo B Bestetti
Journal:  Card Fail Rev       Date:  2016-11

8.  Ischemic stroke classification and risk of embolism in patients with Chagas disease.

Authors:  Vinícius Viana Abreu Montanaro; Creuza Maria da Silva; Carla Verônica de Viana Santos; Maria Inacia Ruas Lima; Edson Marcio Negrão; Gabriel R de Freitas
Journal:  J Neurol       Date:  2016-09-13       Impact factor: 4.849

Review 9.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

10.  Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries.

Authors:  Joana Cortez; Rui Providência; Evelise Ramos; Cristina Valente; Jorge Seixas; Manuela Meruje; António Leitão-Marques; António Vieira
Journal:  World J Cardiol       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.